sVEGFR3 alleviates myocardial ischemia/reperfusion injury through regulating mitochondrial homeostasis and immune cell infiltration
Apoptosis · 2025-04 · 30 (3-4) · 894-911
DOI: 10.1007/s10495-024-02068-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift Apoptosis, online erschienen am 25.01.2025. Verfasst von Liqun Shang und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiac Surgery, First Affiliated Hospital of Sun Yat-sen University, 58 Zhongshan II Rd, Guangzhou, 510080, China. Hauptthemen laut MEDLINE: Myocardial Reperfusion Injury, Vascular Endothelial Growth Factor Receptor-3, Mitochondria. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 75 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key R&D Program of China.
Abstract (Originalsprache)
Recent studies have suggested that sVEGFR3 is involved in cardiac diseases by regulating lymphangiogenesis; however, results are inconsistent. The aim of this study was to investigate the function and mechanism of sVEGFR3 in myocardial ischemia/reperfusion injury (MI/RI). sVEGFR3 effects were evaluated in vivo in mice subjected to MI/RI, and in vitro using HL-1 cells exposed to oxygen-glucose deprivation/reperfusion. Echocardiography, TTC-Evans blue staining, ELISA, electron microscopy, immunofluorescence, western blotting, and flow cytometry were used to investigate whether sVEGFR3 attenuates I/R injury. Transcriptome sequencing was used to investigate the downstream mechanism of sVEGFR3. Results showed that, in vivo, sVEGFR3 pretreatment reduced cardiac dysfunction, infarct area, and myocardial injury indicators by reducing ROS production, AIF expression, and apoptosis. In vitro, sVEGFR3 restored mitochondrial homeostasis by stabilizing the mitochondrial membrane potential (MMP) and preventing the opening of mitochondrial permeability transition pores (mPTP). And sVEGFR3 inhibits mitochondrial apoptosis through the Ras/MEK/ERK pathway. Furthermore, I/R injury increased the proportion of M1 macrophages and CD4 + T cells in myocardial tissue, as well as serum IFN-γ and TNF-α levels, whereas sVEGFR3 treatment attenuated these effects. sVEGFR3 attenuates MI/RI by regulating mitochondrial homeostasis and immune cell infiltration, and reduces intrinsic ROS-mediated mitochondrial apoptosis via the Ras/MEK/ERK pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiac Surgery, First Affiliated Hospital of Sun Yat-sen University, 58 Zhongshan II Rd, Guangzhou, 510080, China.
- Department of Thoracic Surgery, Guangxi Medical University Cancer Hospital, Nanning, China.
- Department of Surgery, Columbia University, New York, NY, USA.
- Department of Cardiovascular Surgery, Shenzhen People's Hospital, Shenzhen, China.
- Department of Cardiac Surgery, First Affiliated Hospital of Sun Yat-sen University, 58 Zhongshan II Rd, Guangzhou, 510080, China. huangsuiqing@126.com.
- Department of Cardiac Surgery, First Affiliated Hospital of Sun Yat-sen University, 58 Zhongshan II Rd, Guangzhou, 510080, China. chnhouj@163.com.
Förderung
- National Natural Science Foundation of China
- National Key R&D Program of China
Zitieren
APA
Shang, L., Ao, Y., Huang, X., Wu, H., Feng, K., Wang, J., Yue, Y., Zhou, Z., Liu, Q., Li, H., Fu, G., Liu, K., Pan, J., Huang, Y., Chen, J., Chen, G., Liang, M., Yao, J., Huang, S., …, & Wu, Z. (2025). sVEGFR3 alleviates myocardial ischemia/reperfusion injury through regulating mitochondrial homeostasis and immune cell infiltration. Apoptosis, 30(3-4), 894-911. https://doi.org/10.1007/s10495-024-02068-8
Vancouver
Shang L, Ao Y, Huang X, Wu H, Feng K, Wang J, et al. sVEGFR3 alleviates myocardial ischemia/reperfusion injury through regulating mitochondrial homeostasis and immune cell infiltration. Apoptosis. 2025;30(3-4):894-911. doi:10.1007/s10495-024-02068-8
BibTeX
@article{Shang2025,
author = {Shang, Liqun and Ao, Yuanhan and Huang, Xiaolin and Wu, Huawei and Feng, Kangni and Wang, Junjie and Yue, Yuan and Zhou, Zhuoming and Liu, Quan and Li, Huayang and Fu, Guangguo and Liu, Kaizheng and Pan, Jinyu and Huang, Yang and Chen, Jiantao and Chen, Guangxian and Liang, Mengya and Yao, Jianping and Huang, Suiqing and Hou, Jian and Wu, Zhongkai},
title = {sVEGFR3 alleviates myocardial ischemia/reperfusion injury through regulating mitochondrial homeostasis and immune cell infiltration},
journal = {Apoptosis},
year = {2025},
volume = {30},
number = {3-4},
pages = {894--911},
doi = {10.1007/s10495-024-02068-8}
}
EUVIMED